Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: Stuki who wrote (56813)	9/14/2006 1:42:46 PM
From: knucklehead	Respond to of 120415

PVCT: Great news on PVCT today. I expect a strategic partner is in the wings to be announced soon based on the latest clinical cancer trials. PVCT's cancer technology may be the coming breakthrough in cancer elimination['solid tumors] without radiation and chemotherapy.

To: Stuki who wrote (56813)	9/14/2006 1:53:53 PM
From: Jeffrey Beckman	Respond to of 120415

DCTH- I have a small remnant position, not exactly a true remnant but a few shares that I bought back after giving up on my larger small remnant around 4.5. What I'm wondering is, do you think one could hold off and buy the stock with FDA approval at a reasonable level? You know, after any such approval, there's no guarantee the level of sales would immediately justify a $20 stock price. Reality could set in if they start reporting $1M/Q in sales without a big profit. Anyway, do you think it could be bought at $8 post-FDA approval?